ATE246001T1 - Supar stimulierende aktivität auf die tcupa vermittelte fibrinolyse und verschiedene verwendungen davon - Google Patents

Supar stimulierende aktivität auf die tcupa vermittelte fibrinolyse und verschiedene verwendungen davon

Info

Publication number
ATE246001T1
ATE246001T1 AT00915328T AT00915328T ATE246001T1 AT E246001 T1 ATE246001 T1 AT E246001T1 AT 00915328 T AT00915328 T AT 00915328T AT 00915328 T AT00915328 T AT 00915328T AT E246001 T1 ATE246001 T1 AT E246001T1
Authority
AT
Austria
Prior art keywords
tcupa
supar
complex
clots
various uses
Prior art date
Application number
AT00915328T
Other languages
English (en)
Inventor
Abd Al-Roof Higazi
Original Assignee
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Med Res Service filed Critical Hadasit Med Res Service
Application granted granted Critical
Publication of ATE246001T1 publication Critical patent/ATE246001T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AT00915328T 1999-04-05 2000-04-03 Supar stimulierende aktivität auf die tcupa vermittelte fibrinolyse und verschiedene verwendungen davon ATE246001T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL129332A IL129332A (en) 1999-04-05 1999-04-05 suPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF
PCT/IL2000/000208 WO2000059535A2 (en) 1999-04-05 2000-04-03 suPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF

Publications (1)

Publication Number Publication Date
ATE246001T1 true ATE246001T1 (de) 2003-08-15

Family

ID=11072681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915328T ATE246001T1 (de) 1999-04-05 2000-04-03 Supar stimulierende aktivität auf die tcupa vermittelte fibrinolyse und verschiedene verwendungen davon

Country Status (9)

Country Link
US (1) US6861054B2 (de)
EP (1) EP1165121B1 (de)
JP (1) JP2002541119A (de)
AT (1) ATE246001T1 (de)
AU (1) AU773562B2 (de)
CA (1) CA2368183A1 (de)
DE (1) DE60004185T2 (de)
IL (1) IL129332A (de)
WO (1) WO2000059535A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2216348C1 (ru) * 2002-11-14 2003-11-20 Общество с ограниченной ответственностью "Научно-производственное предприятие "Техноген" Фармацевтическая композиция, обладающая тромболитическим и фибринолитическим действием

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891664A (en) * 1989-04-07 1999-04-06 Cancerforskningsfondet Af 1989 Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)
WO1994021294A1 (en) 1993-03-19 1994-09-29 Bigner Darell D Method of treating tumors with antibodies
US5455044A (en) 1993-05-14 1995-10-03 Depotech Corporation Method for treating neurological disorders
JP2001505907A (ja) * 1996-12-09 2001-05-08 ハダシット、メディカル、リサーチ、サーヴィセズ、アンド、デヴェロップメント、カンパニー、リミテッド ｓｃｕＰＡ／ｓｕＰＡＲ複合体の医療への使用
AU7036398A (en) * 1997-03-20 1998-10-20 Fondazione Centro San Raffaele Del Monte Tabor Upar mimicking peptide

Also Published As

Publication number Publication date
US6861054B2 (en) 2005-03-01
CA2368183A1 (en) 2000-10-12
WO2000059535A3 (en) 2001-03-01
EP1165121A2 (de) 2002-01-02
AU773562B2 (en) 2004-05-27
IL129332A (en) 2006-12-10
AU3668500A (en) 2000-10-23
US20020022025A1 (en) 2002-02-21
DE60004185T2 (de) 2004-04-22
IL129332A0 (en) 2000-02-17
WO2000059535A2 (en) 2000-10-12
EP1165121B1 (de) 2003-07-30
JP2002541119A (ja) 2002-12-03
DE60004185D1 (de) 2003-09-04

Similar Documents

Publication Publication Date Title
EP1232254A4 (de) VERFAHREN ZUR HERSTELLUNG EINER REVERSIBEL INAKTIVEN, ANGESäUERTEN PLASMINZUSAMMENSETZUNG
IL222773B (en) Biaryl compounds, pharmaceutical compositions comprising the same, use of such compounds in the manufacture of medicaments and in vitro methods and devices using such compounds
MXPA03009130A (es) Compuestos de biarilo que funcionan como inhibidores de proteasa serina.
ATE268766T1 (de) Stickstoff enthaltende heterobicyclen als factor xa inhibitoren
ATE155812T1 (de) Aktivierbare fibrinolytische und antithrombotische proteine
WO2002095007A3 (en) Conjugates activated by cell surface proteases and therapeutic uses thereof
IL205695A0 (en) Compositions containing dspa alpha 1 for the treatment of stroke
ATE108206T1 (de) Gewebe-plasminogenaktivator.
ATE246001T1 (de) Supar stimulierende aktivität auf die tcupa vermittelte fibrinolyse und verschiedene verwendungen davon
AU2001232736A1 (en) Protein c derivatives
Becker Thrombin antagonists and antiplatelet agents
WO2003053999A3 (de) Selektive arylguanidinpeptide als urokinaseinhibitoren
DE59813914D1 (de) Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen
DE69532123D1 (de) Thrombolytische zusammensetzungen
JP2004534837A5 (de)
DE3888619D1 (de) Modifizierter Gewebeplasminogenaktivator.
ATE249239T1 (de) Medizinische verwendung des scupa/supar komplexes
Grau Department of Neurology
Collen Fibrin-Specific Thrombolysis with Tissue-Type Plasminogen Activator and Single Chain Urokinase-Type Plasminogen Activator
JPH0769901A (ja) デキストランサルフェイトのプラスミノゲンアクチベータ インヒビター抑制による線溶活性増強法

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties